Skip to main content
logo
Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India flag India · Delayed Price · Currency is INR
1,197.50
+1.50 (0.13%)
Nov 4, 2025, 3:30 PM IST

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 88.05B INR in the quarter ending September 30, 2025, with 9.84% growth. This brings the company's revenue in the last twelve months to 342.15B, up 14.10% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
342.15B
Revenue Growth
+14.10%
P/S Ratio
2.92
Revenue / Employee
12.30M
Employees
27,811
Market Cap
999.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Aurobindo Pharma320.25B
Cipla279.66B
Zydus Lifesciences236.08B
Apollo Hospitals Enterprise225.51B
Glenmark Pharmaceuticals134.56B
Alkem Laboratories133.04B
Mankind Pharma129.10B
Revenue Rankings

Dr. Reddy's Laboratories News

More News